Last week the US FDA refused to approve the Moderna mRNA flu vaccine because of the inadequacy of trial design.
Right away the virulence and reach of...
A paper published in the Journal of the American Geriatric Society entitled "Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed-methods study" throws a...
On the Friday before Christmas, Health New Zealand quietly released the 2023 New Zealand cancer data to a media preoccupied with end of year holiday trivia. Not...
I find myself perplexed that commercial pharmaceutical enterprises, despite huge areas of uncertainty around safety and outcomes, felt that they could launch their experimental...
Every global shift in power has its own quasi scientific philosophy.
At first sight, the pandemic has brought together unusual bedfellows into a nascent global...